TransThera Sciences Completes HK$156.62 Million H Share Placement for Tinengotinib Development and Corporate Purposes
TransThera Sciences (Nanjing), Inc. Announces Successful Com...
Sign in to continue:
TransThera Sciences (Nanjing), Inc. Announces Successful Com...
Qyuns Therapeutics Receives Milestone Payment from Roche ...
PATEO CONNECT Technology (Shanghai) Corporation 2026 Q1 Busi...
Valuetronics Holdings Limited FY2026 Results: Analysis and I...
Ling Yui Holdings - Detailed Offer Closure and Clarification...
Valuetronics Holdings Limited FY2026 Financial Results Analy...
Pharmaron Beijing Announces Major Investment in Shaoxing API...
Consun Pharmaceutical Announces HKD200 Million Share Repurch...
Chasen Holdings Limited FY2026 Financial Results Analysis C...
Cocoon Holdings Limited: SGM Poll Results and Price-Sensitiv...